PE20090275A1 - Derivados de oxazepinaminas o tiazepinaminas como moduladores de receptores de progesterona - Google Patents

Derivados de oxazepinaminas o tiazepinaminas como moduladores de receptores de progesterona

Info

Publication number
PE20090275A1
PE20090275A1 PE2008000799A PE2008000799A PE20090275A1 PE 20090275 A1 PE20090275 A1 PE 20090275A1 PE 2008000799 A PE2008000799 A PE 2008000799A PE 2008000799 A PE2008000799 A PE 2008000799A PE 20090275 A1 PE20090275 A1 PE 20090275A1
Authority
PE
Peru
Prior art keywords
oxazepin
pyrid
dibenzo
trifluoro
acetamide
Prior art date
Application number
PE2008000799A
Other languages
English (en)
Inventor
Johannes Bernardus Maria Rewinkel
Brigitte Johanna Bernita Folmer
Ollero Maria Lourdes Ollero
Ibrahim Hemen
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of PE20090275A1 publication Critical patent/PE20090275A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)

Abstract

REFERIDA A UN COMPUESTO DERIVADO DE OXAZEPINAMINA O TIAZEPINAMINA DE FORMULA (I), DONDE R1 ES ACILO C1-C5, TIOACILO C1-C5, ALQUILSULFONILO C1-C4, ENTRE OTROS; R2 Y R3 SON H, HALOGENO, CIANO, NITRO O TIOCARBAMILO; R4 Y R5 SON H, ALQUILO C1-C4, ALCOXI C1-C4; X ES -O-, -S-, -SO- Y -SO2-. SON COMPUESTOS PREFERIDOS: CIS-N-[8-BROMO-1,3,4,14b-DIHIDRO-14-METIL-2H-DIBENZO[b,f]PIRIDO[1,2-d][1,4]OXAZEPIN-2-IL]-2,2,2-TRIFLUORO-ACETAMIDA, (-)-CIS-N-[8-CIANO-1,3,4,14b-DIHIDRO-14-METIL-2H-DIBENZO[b,f]PIRIDO[1,2-d][1,4]OXAZEPIN-2-IL]-2,2,2-TRIFLUORO-ACETAMIDA, (±)-CIS-N-[7-FLUORO-1,3,4,14b-DIHIDRO-14-METIL-2H-DIBENZO[b,f]PIRIDO[1,2-d][1,4]OXAZEPIN-2-IL]-2,2,2-TRIFLUORO-ACETAMIDA, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS TIENEN ACTIVIDAD MODULADORA SOBRE LOS RECEPTORES DE PROGESTERONA Y SON UTILES EN LA TERAPIA DE REEMPLAZO HORMONAL, DE TRANSTORNOS GINECOLOGICOS, EN LA TERAPIA ADYUNVANTE EN EL CANCER, ENTRE OTRAS ENFERMEDADES
PE2008000799A 2007-05-07 2008-05-07 Derivados de oxazepinaminas o tiazepinaminas como moduladores de receptores de progesterona PE20090275A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07107639 2007-05-07

Publications (1)

Publication Number Publication Date
PE20090275A1 true PE20090275A1 (es) 2009-03-21

Family

ID=38535595

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008000799A PE20090275A1 (es) 2007-05-07 2008-05-07 Derivados de oxazepinaminas o tiazepinaminas como moduladores de receptores de progesterona

Country Status (18)

Country Link
EP (1) EP2155757B1 (es)
JP (1) JP2010526113A (es)
KR (1) KR20100021438A (es)
CN (1) CN101679455A (es)
AR (1) AR066467A1 (es)
AU (1) AU2008248873B8 (es)
BR (1) BRPI0813158A2 (es)
CA (1) CA2684088A1 (es)
CL (1) CL2008001333A1 (es)
CO (1) CO6260140A2 (es)
EC (1) ECSP099753A (es)
IL (1) IL201484A0 (es)
MX (1) MX2009012063A (es)
PE (1) PE20090275A1 (es)
RU (1) RU2009149856A (es)
TW (1) TW200914029A (es)
WO (1) WO2008135291A1 (es)
ZA (1) ZA200907546B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112019012300A2 (pt) * 2016-12-15 2019-11-12 Glaxosmithkline Ip Dev Ltd ativadores nrf2

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI297685B (en) * 2002-04-04 2008-06-11 Organon Nv Non-steroidal progesterone receptor modulators
TWI370129B (en) * 2005-02-14 2012-08-11 Msd Oss Bv Non steroidal glucocorticoid receptor modulators

Also Published As

Publication number Publication date
IL201484A0 (en) 2010-05-31
JP2010526113A (ja) 2010-07-29
CO6260140A2 (es) 2011-03-22
AU2008248873B2 (en) 2013-01-10
ECSP099753A (es) 2009-12-28
TW200914029A (en) 2009-04-01
EP2155757A1 (en) 2010-02-24
MX2009012063A (es) 2009-11-19
AU2008248873A8 (en) 2013-05-09
CN101679455A (zh) 2010-03-24
RU2009149856A (ru) 2011-06-20
KR20100021438A (ko) 2010-02-24
EP2155757B1 (en) 2012-10-31
CL2008001333A1 (es) 2008-10-03
AR066467A1 (es) 2009-08-19
BRPI0813158A2 (pt) 2014-12-23
ZA200907546B (en) 2010-07-28
CA2684088A1 (en) 2008-11-13
AU2008248873B8 (en) 2013-05-09
AU2008248873A1 (en) 2008-11-13
WO2008135291A1 (en) 2008-11-13

Similar Documents

Publication Publication Date Title
SV2010003580A (es) Agonistas novedosos de los receptores de glucocorticoides
CR9022A (es) Derivados de sulfonamida novedosos como moduladores de receptor de glucocorticoides para el tratamiento de enfermedades inflamatorias
AR035774A1 (es) Derivados benzimidazol y piridilimidazol, un procedimiento para su preparacion, composiciones farmaceuticas y paquetes que los comprenden, el uso de dichos compuestos solos o en combinacion para la manufactura de medicamentos como ligandos para gabaa, y metodo de tratamiento
UY28150A1 (es) Agentes terapeuticos
AR063211A1 (es) Derivados de 3-(piridin-3-il)acrilamida y 3-(piridin-3-il)propionamida, un metodo para su preparacion, una composicion farmaceutica que los comprende y su uso en la fabricacion de medicamentos para el tratamiento de enfermedades asociadas con el receptor vaniloide.
CR10489A (es) Derivados fenil-pirazol como ligandos de receptores glucocorticoides no esteroides
CR10922A (es) Derivados de indol como antagonistas receptores de s1p1
PE20060555A1 (es) Derivados de pirrol-oxindol como moduladores del receptor de progesterona
AR079327A1 (es) Derivados de 2-amino-5,5-difluor -5,6-dihidro-4h-(1,3) oxazin-4-il) fenil)-amida
ECSP077323A (es) Nuevos derivados de sulfonamida como moduladores del receptor de glucocorticoides para el tratamiento de enfermedades inflamatorias
PE20080947A1 (es) Derivados de n-(amino-heteroaril)-1h-indol-2-carboxamidas como antagonistas de receptores de tipo trpv1
CR7643A (es) Derivados de 1-heterociclialquil -3-sulfonilazaindol o azaindazol como ligandos de 5-hidroxitriptamina-6
ECSP055964A (es) Heterociclil-3-sulfonilindazoles como ligandos de 5-hidroxitriptamina-6
NO20064365L (no) Terapeutisk forbindelse
PE20090049A1 (es) Derivados de piridopirimidina como moduladores de la actividad de pde 4
CU23282A3 (es) DERIVADOS DEL TROPANO ÃsTILES EN TERAPIA
AR045762A1 (es) Derivados de quinazolina
ECSP088648A (es) Nuevos bencimidazoles 2-sustituidos como moduladores de receptor de androgeno selectivos (sarms)
MY137609A (en) Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation
ECSP045473A (es) Derivados de 1-(aminoalquil)-3-sulfonilindol y 1-aminoalquil-3-sulfonilindazol como ligandos de 5-hidroxitriptamina-6
AR072228A1 (es) Derivados de pirimido isoquinolina sustituidos
ECSP099425A (es) Derivados de amina y su uso en enfermedades mediadas por el adrenorecetor beta 2
UY31672A1 (es) "agonistas de receptores muscarínicos composiciones farmacéuticas métodos de tratamiento de los mismos, y procedimientos para su preparación"
AR069607A1 (es) Inhibidores de la estearoil-coa desaturasa
AR077124A1 (es) Agentes antihelminticos y su uso

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed